Benefit-Risk Analysis: A Brief Review and Proposed Quantitative Approaches

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.12, 2003-01, pp. : 853-862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantitative Benefit-Risk Analysis for Evaluating Drug Therapies

By Kodell Ralph L. Chen James J.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 231-238

Taylor & Francis Ltd

Access to resources Recommend Favorite

Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome

By Lynd Larry D. Najafzadeh Mehdi Colley Lindsey Byrne Michael F. Willan Andrew R. Sculpher Mark J. Johnson F. Reed Hauber A. Brett

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 411-417

Blackwell Publishing

Access to resources Recommend Favorite

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 1: In Major Surgery

By Fraser Ian S.

Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. : 217-230

Adis International

Access to resources Recommend Favorite

The Levonorgestrel-Releasing Intrauterine System in Heavy Menstrual Bleeding: A Benefit-Risk Review

By Kaunitz Andrew M.

Drugs, Vol. 72, Iss. 2, 2012-01 ,pp. : 193-215

Adis International

Access to resources Recommend Favorite

Evaluation of Benefit-Risk

By Garattini Silvio

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 981-986

Adis International

Access to resources Recommend Favorite